Pierre-Yves Dietrich
Klinik Hirslanden(CH)Hirslanden Clinique des Grangettes(CH)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Epigenetics and DNA Methylation, CAR-T cell therapy research
Most-Cited Works
- → Actively personalized vaccination trial for newly diagnosed glioblastoma(2018)910 cited
- → Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant Temozolomide(2002)815 cited
- → Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastoma Patients Treated with Temozolomide(2004)788 cited
- → Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival(2012)780 cited
- → Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma(2010)443 cited
- → MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status(2012)358 cited
- → Long-Term Follow-Up of Patients With Follicular Lymphoma Receiving Single-Agent Rituximab at Two Different Schedules in Trial SAKK 35/98(2010)241 cited
- → Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer(2021)240 cited
- → Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma(2017)162 cited
- → CAR T-Cell Therapies in Glioblastoma: A First Look(2017)131 cited